119 related articles for article (PubMed ID: 30670147)
1. 2-(trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate enhances thrombopoietin-induced megakaryocytic differentiation and plateletogenesis.
Kim J; Jin G; Lee J; Lee K; Bae YS; Kim J
BMB Rep; 2019 Jul; 52(7):434-438. PubMed ID: 30670147
[TBL] [Abstract][Full Text] [Related]
2. 2-(trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate promotes megakaryocytic differentiation of myeloid leukaemia cells and primary human CD34⁺ haematopoietic stem cells.
Limb JK; Song D; Jeon M; Han SY; Han G; Jhon GJ; Bae YS; Kim J
J Tissue Eng Regen Med; 2015 Apr; 9(4):435-46. PubMed ID: 23166016
[TBL] [Abstract][Full Text] [Related]
3. 2-(trimethylammonium) ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate suppresses osteoclast maturation and bone resorption by targeting macrophage-colony stimulating factor signaling.
Park SJ; Park DR; Bhattarai D; Lee K; Kim J; Bae YS; Lee SY
Mol Cells; 2014 Aug; 37(8):628-35. PubMed ID: 25139265
[TBL] [Abstract][Full Text] [Related]
4. In vitro large scale production of megakaryocytes to functional platelets from human hematopoietic stem cells.
Kumar PS; Chandrasekhar C; Srikanth L; Sarma PVGK
Biochem Biophys Res Commun; 2018 Oct; 505(1):168-175. PubMed ID: 30243726
[TBL] [Abstract][Full Text] [Related]
5. Murine prolactin-like protein E synergizes with human thrombopoietin to stimulate expansion of human megakaryocytes and their precursors.
Lefebvre P; Lin J; Linzer DI; Cohen I
Exp Hematol; 2001 Jan; 29(1):51-8. PubMed ID: 11164105
[TBL] [Abstract][Full Text] [Related]
6. Megakaryothrombopoiesis during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin.
Woo SY; Kie JH; Ryu KH; Moon HS; Chung WS; Hwang DH; Kim SK; Han TH; Hahn MJ; Chong YH; Park HK; Seoh JY
Scand J Immunol; 2002 Jan; 55(1):88-95. PubMed ID: 11841696
[TBL] [Abstract][Full Text] [Related]
7. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin.
Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y
J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635
[TBL] [Abstract][Full Text] [Related]
8. Effects of c-mpl ligand on cytoplasmic maturation of murine megakaryocytes and on platelet production.
Ishida Y; Ito T; Kuriya Si
J Histochem Cytochem; 1998 Jan; 46(1):49-57. PubMed ID: 9405494
[TBL] [Abstract][Full Text] [Related]
9. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
10. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
Proulx C; Boyer L; Hurnanen DR; Lemieux R
J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin: understanding and manipulating platelet production.
Kaushansky K
Annu Rev Med; 1997; 48():1-11. PubMed ID: 9046940
[TBL] [Abstract][Full Text] [Related]
12. H2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets.
Liu HD; Zhang AJ; Xu JJ; Chen Y; Zhu YC
J Hematol Oncol; 2016 Feb; 9():13. PubMed ID: 26912146
[TBL] [Abstract][Full Text] [Related]
13. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
[TBL] [Abstract][Full Text] [Related]
15. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
[TBL] [Abstract][Full Text] [Related]
16. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
17. Terminal megakaryocytic differentiation of TF-1 cells is induced by phorbol esters and thrombopoietin and is blocked by expression of PML/RARalpha fusion protein.
Testa U; Grignani F; Hassan HJ; Rogaia D; Masciulli R; Gelmetti V; Guerriero R; Macioce G; Liberatore C; Barberi T; Mariani G; Pelicci PG; Peschle C
Leukemia; 1998 Apr; 12(4):563-70. PubMed ID: 9557615
[TBL] [Abstract][Full Text] [Related]
18. Effect of thrombopoietin on the development of megakaryocytes and platelets: an ultrastructural analysis.
Zucker-Franklin D; Kaushansky K
Blood; 1996 Sep; 88(5):1632-8. PubMed ID: 8781418
[TBL] [Abstract][Full Text] [Related]
19. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N
Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176
[TBL] [Abstract][Full Text] [Related]
20. Developing a co-culture system for effective megakaryo/thrombopoiesis from umbilical cord blood hematopoietic stem/progenitor cells.
Hatami J; Andrade PZ; Alves de Matos AP; Djokovic D; Lilaia C; Ferreira FC; Cabral JM; da Silva CL
Cytotherapy; 2015 Apr; 17(4):428-42. PubMed ID: 25680300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]